Facts on factor VIII prevention of haemophilic arthropathy

Author：  

Publisher： Adis International

ISSN： 1173-8324

Source： Inpharma, Vol.1, Iss.1601, 2007-01, pp. : 9-9

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Factor VIII – Baxter: rAHF-PFM, Recombinant Anti-Haemophilic Factor – Protein-Free Method, Recombinant Factor VIII – Protein-Free

By Limited A.I.  

Drugs in R&D, Vol. 4, Iss. 6, 2003-01 ,pp. : 366-368

Adis International

Access to resources Recommend Favorite

Factor VIII: Thrombosis in a haemophilia A carrier: case report

By  

Reactions Weekly, Vol. 1, Iss. 1051, 2005-01 ,pp. : 10-10

Adis International

Access to resources Recommend Favorite

Factor VIII: Fatal pulmonary embolism?: case report

By  

Reactions Weekly, Vol. 1, Iss. 1262, 2009-01 ,pp. : 13-14

Adis International

Access to resources Recommend Favorite

Factor VIII/von Willebrand factor: Development of alloantibodies against von Willebrand factor: case report

By  

Reactions Weekly, Vol. 1, Iss. 1426, 2012-01 ,pp. : 23-23

Adis International

Access to resources Recommend Favorite

Peginterferon: Factor VIII inhibitor development, subconjunctival haemorrhage and haematoma: case report

By  

Reactions Weekly, Vol. 1, Iss. 1146-1147, 2007-01 ,pp. : 22-22

Adis International

Access to resources Recommend Favorite